The NIFTY test is a non-invasive prenatal test, intended for the detection of several chromosomal aneuploidies (chromosomes 13, 18, 21, and sex chromosomes) and large structural variations (84 types of microdeletion and microduplication syndromes including Di George Syndrome). The test is assisting your OB\GYN to rule out a set of genetic syndromes that may affect your fetus at a high level of confidence. The test requires a small volume of maternal blood sample and is effective from as early as week 10 of pregnancy. NIFTY offers higher rates of accuracy than traditional screening tests and, unlike invasive procedures such as amniocentesis, poses no miscarriage risk to the mother. To date, over 10 million NIFTY tests have been performed worldwide.For more information, please visit here.